Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B

Yao Shih Hsu, Rong Nan Chien, Chau Ting Yeh, I. Shyan Sheen, Hung Yi Chiou, Chia Ming Chu, Yun Fan Liaw

Research output: Contribution to journalArticle

518 Citations (Scopus)

Abstract

During the course of chronic hepatitis B virus (HBV) infection, hepatitis B e antigen (HBeAg) seroconversion to its antibody (anti-HBe) often coincides with normalization of liver biochemical test and clinical remission, but data regarding long-term outcome after spontaneous seroconversion are still scarce. Excluding patients with other virus(es) concurrent infection, 283 patients with chronic HBV infection were followed up for at least 1 year after spontaneous HBeAg seroconversion to anti-HBe. Follow-up studies included clinical, biochemical, and virologic evaluation and hepatocellular carcinoma (HCC) screening with ultrasonography and α-fetoprotein assay. During a median follow-up period of 8.6 years (range, 1 to 18.4 years) after HBeAg seroconversion in 283 patients, 189 (66.8%) showed sustained remission, whereas the remaining 94 (33.2%) experienced alanine aminotransferase (ALT) elevation over twice the upper limit of normal: 12 (4.2%) associated with HBeAg reversion, 68 (24%) with detectable serum HBV DNA but HBeAg negative, and 14 (4.9%) of undetermined causes. Of the 269 patients without evidence of cirrhosis at the time of HBeAg seroconversion, 21 (7.8%) developed cirrhosis with a cumulative incidence and relative risk significantly higher in patients developing active hepatitis than in patients with sustained remission (P <.05). HCC developed in 6 (2.2%) of the 283 patients, also with a significantly higher cumulative incidence in patients developing active hepatitis after HBeAg seroconversion (P <.005). In conclusion, the results suggest that spontaneous HBeAg seroconversion confers favorable long-term outcomes. However, active hepatitis still may develop and lead to cirrhosis and HCC.

Original languageEnglish
Pages (from-to)1522-1527
Number of pages6
JournalHepatology
Volume35
Issue number6
DOIs
Publication statusPublished - Jun 2002
Externally publishedYes

Fingerprint

Hepatitis B e Antigens
Chronic Hepatitis B
Hepatitis B virus
Hepatitis
Hepatocellular Carcinoma
Fibrosis
Virus Diseases
Fetal Proteins
Seroconversion
Incidence
Alanine Transaminase
Anti-Idiotypic Antibodies
Ultrasonography
Viruses
Liver
DNA
Infection
Serum

Keywords

  • Hepatitis B
  • Spontaneous
  • Risk Factors

ASJC Scopus subject areas

  • Hepatology

Cite this

Hsu, Y. S., Chien, R. N., Yeh, C. T., Sheen, I. S., Chiou, H. Y., Chu, C. M., & Liaw, Y. F. (2002). Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology, 35(6), 1522-1527. https://doi.org/10.1053/jhep.2002.33638

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. / Hsu, Yao Shih; Chien, Rong Nan; Yeh, Chau Ting; Sheen, I. Shyan; Chiou, Hung Yi; Chu, Chia Ming; Liaw, Yun Fan.

In: Hepatology, Vol. 35, No. 6, 06.2002, p. 1522-1527.

Research output: Contribution to journalArticle

Hsu, YS, Chien, RN, Yeh, CT, Sheen, IS, Chiou, HY, Chu, CM & Liaw, YF 2002, 'Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B', Hepatology, vol. 35, no. 6, pp. 1522-1527. https://doi.org/10.1053/jhep.2002.33638
Hsu, Yao Shih ; Chien, Rong Nan ; Yeh, Chau Ting ; Sheen, I. Shyan ; Chiou, Hung Yi ; Chu, Chia Ming ; Liaw, Yun Fan. / Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. In: Hepatology. 2002 ; Vol. 35, No. 6. pp. 1522-1527.
@article{d59221947fc142c29e567b271a05e423,
title = "Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B",
abstract = "During the course of chronic hepatitis B virus (HBV) infection, hepatitis B e antigen (HBeAg) seroconversion to its antibody (anti-HBe) often coincides with normalization of liver biochemical test and clinical remission, but data regarding long-term outcome after spontaneous seroconversion are still scarce. Excluding patients with other virus(es) concurrent infection, 283 patients with chronic HBV infection were followed up for at least 1 year after spontaneous HBeAg seroconversion to anti-HBe. Follow-up studies included clinical, biochemical, and virologic evaluation and hepatocellular carcinoma (HCC) screening with ultrasonography and α-fetoprotein assay. During a median follow-up period of 8.6 years (range, 1 to 18.4 years) after HBeAg seroconversion in 283 patients, 189 (66.8{\%}) showed sustained remission, whereas the remaining 94 (33.2{\%}) experienced alanine aminotransferase (ALT) elevation over twice the upper limit of normal: 12 (4.2{\%}) associated with HBeAg reversion, 68 (24{\%}) with detectable serum HBV DNA but HBeAg negative, and 14 (4.9{\%}) of undetermined causes. Of the 269 patients without evidence of cirrhosis at the time of HBeAg seroconversion, 21 (7.8{\%}) developed cirrhosis with a cumulative incidence and relative risk significantly higher in patients developing active hepatitis than in patients with sustained remission (P <.05). HCC developed in 6 (2.2{\%}) of the 283 patients, also with a significantly higher cumulative incidence in patients developing active hepatitis after HBeAg seroconversion (P <.005). In conclusion, the results suggest that spontaneous HBeAg seroconversion confers favorable long-term outcomes. However, active hepatitis still may develop and lead to cirrhosis and HCC.",
keywords = "Hepatitis B, Spontaneous, Risk Factors, Hepatitis B, Spontaneous, Risk Factors",
author = "Hsu, {Yao Shih} and Chien, {Rong Nan} and Yeh, {Chau Ting} and Sheen, {I. Shyan} and Chiou, {Hung Yi} and Chu, {Chia Ming} and Liaw, {Yun Fan}",
year = "2002",
month = "6",
doi = "10.1053/jhep.2002.33638",
language = "English",
volume = "35",
pages = "1522--1527",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B

AU - Hsu, Yao Shih

AU - Chien, Rong Nan

AU - Yeh, Chau Ting

AU - Sheen, I. Shyan

AU - Chiou, Hung Yi

AU - Chu, Chia Ming

AU - Liaw, Yun Fan

PY - 2002/6

Y1 - 2002/6

N2 - During the course of chronic hepatitis B virus (HBV) infection, hepatitis B e antigen (HBeAg) seroconversion to its antibody (anti-HBe) often coincides with normalization of liver biochemical test and clinical remission, but data regarding long-term outcome after spontaneous seroconversion are still scarce. Excluding patients with other virus(es) concurrent infection, 283 patients with chronic HBV infection were followed up for at least 1 year after spontaneous HBeAg seroconversion to anti-HBe. Follow-up studies included clinical, biochemical, and virologic evaluation and hepatocellular carcinoma (HCC) screening with ultrasonography and α-fetoprotein assay. During a median follow-up period of 8.6 years (range, 1 to 18.4 years) after HBeAg seroconversion in 283 patients, 189 (66.8%) showed sustained remission, whereas the remaining 94 (33.2%) experienced alanine aminotransferase (ALT) elevation over twice the upper limit of normal: 12 (4.2%) associated with HBeAg reversion, 68 (24%) with detectable serum HBV DNA but HBeAg negative, and 14 (4.9%) of undetermined causes. Of the 269 patients without evidence of cirrhosis at the time of HBeAg seroconversion, 21 (7.8%) developed cirrhosis with a cumulative incidence and relative risk significantly higher in patients developing active hepatitis than in patients with sustained remission (P <.05). HCC developed in 6 (2.2%) of the 283 patients, also with a significantly higher cumulative incidence in patients developing active hepatitis after HBeAg seroconversion (P <.005). In conclusion, the results suggest that spontaneous HBeAg seroconversion confers favorable long-term outcomes. However, active hepatitis still may develop and lead to cirrhosis and HCC.

AB - During the course of chronic hepatitis B virus (HBV) infection, hepatitis B e antigen (HBeAg) seroconversion to its antibody (anti-HBe) often coincides with normalization of liver biochemical test and clinical remission, but data regarding long-term outcome after spontaneous seroconversion are still scarce. Excluding patients with other virus(es) concurrent infection, 283 patients with chronic HBV infection were followed up for at least 1 year after spontaneous HBeAg seroconversion to anti-HBe. Follow-up studies included clinical, biochemical, and virologic evaluation and hepatocellular carcinoma (HCC) screening with ultrasonography and α-fetoprotein assay. During a median follow-up period of 8.6 years (range, 1 to 18.4 years) after HBeAg seroconversion in 283 patients, 189 (66.8%) showed sustained remission, whereas the remaining 94 (33.2%) experienced alanine aminotransferase (ALT) elevation over twice the upper limit of normal: 12 (4.2%) associated with HBeAg reversion, 68 (24%) with detectable serum HBV DNA but HBeAg negative, and 14 (4.9%) of undetermined causes. Of the 269 patients without evidence of cirrhosis at the time of HBeAg seroconversion, 21 (7.8%) developed cirrhosis with a cumulative incidence and relative risk significantly higher in patients developing active hepatitis than in patients with sustained remission (P <.05). HCC developed in 6 (2.2%) of the 283 patients, also with a significantly higher cumulative incidence in patients developing active hepatitis after HBeAg seroconversion (P <.005). In conclusion, the results suggest that spontaneous HBeAg seroconversion confers favorable long-term outcomes. However, active hepatitis still may develop and lead to cirrhosis and HCC.

KW - Hepatitis B

KW - Spontaneous

KW - Risk Factors

KW - Hepatitis B

KW - Spontaneous

KW - Risk Factors

UR - http://www.scopus.com/inward/record.url?scp=0036614299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036614299&partnerID=8YFLogxK

U2 - 10.1053/jhep.2002.33638

DO - 10.1053/jhep.2002.33638

M3 - Article

VL - 35

SP - 1522

EP - 1527

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 6

ER -